How will COVID-19 affect TB patients and control?

Our 2020 World TB Day Symposium has been cancelled because of the COVID-19 pandemic. Here, three experts from University College London (UCL) and the London School of Hygiene & Tropical Medicine (LSHTM) discuss the effect of the pandemic on TB patients and the TB control programme.

  • Beate Kampmann is Professor of Paediatric Infection & Immunity and Director of the Vaccine Centre at the LSHTM, and leads the Vaccines & Immunity research at the MRC Unit in The Gambia, including the childhood TB research programme.
  • Dr Toyin Togun is an Assistant Professor at the LSHTM and a Clinician-Scientist at the MRC Unit The Gambia at LSHTM. He leads the Childhood TB Work Package in the EDCTP-funded West African Nodes of Excellence for TB, AIDS and Malaria (WANETAM) consortium.
  • Marc Lipman is Professor of Medicine at UCL, Consultant in Respiratory and HIV Medicine at the Royal Free London NHS Foundation Trust, and Director of UCL-TB, UCL’s cross-disciplinary TB research grouping.

Video - watch on YouTube:

YouTube Widget Placeholderhttps://youtu.be/XS5LQc0rlzU


Audio - listen on Soundcloud:

TB and COVID-19: TB Alert

You might be interested in related information from our friends at TB Alert, who write:
Over the last few weeks, TB Alert has worked with Public Health England to draw up answers to frequently asked questions about the coronavirus that we have received from concerned individuals. These are available on our TB information website. We are also answering many more enquiries by telephone (07311 437398), email and through our online forum – which are coming in from all over the world.